Clinical Trial Update: A Study Of BOTOX For The Treatment Of Glabellar Lines [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Botox (onabotulinumtoxinA) for the treatment of glabellar lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Lines

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Glabellar Lines | Phase 3 | Status: COMPLETED